| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/28/2008 | WO2008024018A1 Electroluminescent material containing an organic luminescent substance |
| 02/28/2008 | WO2008023044A1 Process for the preparation of montelukast free acid and its amine salts |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | CA2659952A1 8-hydroxyquinoline compounds and methods thereof |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1891076A1 Substituted tetrahydroquinolines |
| 02/27/2008 | EP1891017A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/27/2008 | EP1891012A2 Quinoline derivatives as nk3 anatgonists |
| 02/27/2008 | EP1891011A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
| 02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 02/27/2008 | EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 02/27/2008 | EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133028A Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |
| 02/27/2008 | CN101133010A Process and intermediate compounds useful in the preparation of statins |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/21/2008 | WO2008021491A2 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones |
| 02/21/2008 | US20080045568 Novel high affinity quinoline-based kinase ligands |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045520 Substituted Pyrrolidine Derivative |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/21/2008 | DE202004021379U1 Kristalline Formen von Pitivastatin Calcium Crystalline forms of calcium Pitivastatin |
| 02/21/2008 | CA2695072A1 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/20/2008 | EP1888604A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 02/20/2008 | EP1888548A1 Compositions and methods of treating retinal disease |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888529A2 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same |
| 02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | CN101128431A Novel quinoline derivatives as potassium ion channel openers |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332605 reacting substituted 5,6,7,8-tetrahydroquinolinylamine bearing a phthalimide protecting group or a di-tert-butoxycarbonyl protecting group with an alkyl aldehyde to produce an imine; reduction with metal hydride; reacting the secondary amine with a 2-halomethylbenzimidazole; hydrolysis deprotecting |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332499 N-[(1R)-1-(2-fluoro-4-{1-[(trifluoromethyl)sulfonyl]-1,2,3,4-tetrahydroquinolin-8-yl}phenyl)ethyl]-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide; bradykinin B1 antagonists or inverse agonists; analgesic and antiinflammatory agent; acute and chronic pain |
| 02/19/2008 | CA2359472C Process for producing quinolinecarbaldehyde |
| 02/19/2008 | CA2307824C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor,salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient. |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017669A1 Purification process of montelukast and its amine salts |
| 02/14/2008 | WO2008017667A1 Process for the purification of montelukast |
| 02/14/2008 | WO2007149211B1 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
| 02/14/2008 | US20080039629 Benzothniazole compositions and their use as ubiquition ligation inhibitors |
| 02/14/2008 | US20080039495 Diamine Beta2 Adrenergic Receptor Agonists |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080036373 Platinum complex and light-emitting device |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | CA2657775A1 Purification process of montelukast and its amine salts |
| 02/14/2008 | CA2657017A1 Process for the purification of montelukast |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886998A1 Purification process of montelukast and its amine salts |
| 02/13/2008 | EP1886997A1 Process for the purification of montelukast |
| 02/13/2008 | EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 02/13/2008 | EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 02/13/2008 | EP1273330B1 Sublimation purifying method and apparatus |
| 02/13/2008 | CN101124206A 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 02/07/2008 | WO2008016762A1 Fluorogenic protein kinase substrates |
| 02/07/2008 | WO2008015703A2 Process for the preparation of montelukast and its salts thereof |
| 02/07/2008 | WO2008014602A1 Quinoline derivatives |
| 02/07/2008 | WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 02/07/2008 | US20080033175 Process for preparation of 4-amino-3-quinolinecarbonitriles |
| 02/07/2008 | US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | CA2658793A1 Quinoline derivatives |
| 02/06/2008 | EP1883631A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 02/06/2008 | EP1883630A2 Methods of synthesizing 6-alkylaminoquinoline derivatives |
| 02/06/2008 | EP1883621A2 Methods of preparing 3-cyano-quinolines and intermediates made thereby |
| 02/06/2008 | EP1883403A2 Keratinocyte growth factor receptor - tyrosine specific inhibitors for the prevention of cancer metastatis |
| 02/06/2008 | CN101119717A Substituted phenols as active agents inhibiting vegf production |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008013494A1 Quinoline derivatives as p2x7 receptor antagonist and their use in the treatment of rheumatoid arthritis, osteoarthritis, copd and ibd |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |